X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Arihant Capital Markets Ltd.
BSE CODE: 511605   |   NSE CODE: ARIHANTCAP   |   ISIN CODE : INE420B01036   |   14-Aug-2025 Hrs IST
BSE NSE
Rs. 96.29
-2.67 ( -2.7% )
 
Prev Close ( Rs.)
98.96
Open ( Rs.)
98.88
 
High ( Rs.)
99.23
Low ( Rs.)
95.80
 
Volume
24542
Week Avg.Volume
38069
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 96.29
-2.45 ( -2.48% )
 
Prev Close ( Rs.)
98.74
Open ( Rs.)
98.74
 
High ( Rs.)
98.95
Low ( Rs.)
95.84
 
Volume
218918
Week Avg.Volume
371519
 
52 WK High-Low Range(Rs.)
58.15
124.8
Source DateBoard Meeting DateDetails
22-Jul-2025 25-Jul-2025 Inter alia, to consider and approve the proposal for raising funds by way of issue of equity shares or any other instruments or securities, through one or more of the permissible modes including but not limited to a qualified institutions placement, preferential
30-Jun-2025 07-Jul-2025 Preferential Issue of shares & Quarterly Results Inter alia, to consider and approve:- 1. Fund Raising by way of equity shares or other instruments or securities through permissible modes including QIP or any other permissible mode and/ or combination thereof as may be considered appropriate, subject to such statutory/ regulatory approvals, as applicable. 2. To approve the notice of the Extra-Ordinary General Meeting and Annual General Meeting of the shareholders for obtaining consent on necessary resolutions and matters. 3. Other incidental and ancillary matters.
30-Apr-2025 10-May-2025 Dividend & Audited Results
31-Jan-2025 10-Feb-2025 Quarterly Results
28-Oct-2024 07-Nov-2024 Quarterly Results Inter alia, to consider and approve:- 1. To consider the appointment of Mr. Arpit Jain (DIN: 06544441), Joint Managing Director as the Chief Executive Officer of the Company.
30-Aug-2024 06-Sep-2024 Right Issue of Equity Shares & Inter alia, to consider and approve:- 1. Fund Raising by way of equity shares or other instruments or securities through permissible modes including Right Issue / QIP or any other permissible mode and/ or combination thereof as may be considered appropriate, subject to such statutory/ regulatory approvals, as applicable. 2. Other incidental and ancillary matters.
12-Jul-2024 20-Jul-2024 Quarterly Results
13-Jun-2024 21-Jun-2024 Inter alia, to consider and approve:- 1. Consider and approve the divestment of 100% Equity stake/investment held in its wholly owned subsidiary company viz., Arihant Insurance Broking Services Limited subject to the approval of IRDAI. 2. Other incidental and ancillary matters.
22-May-2024 25-May-2024 Issue Of Warrants
13-May-2024 21-May-2024 Audited Results & Final Dividend
Page 1 of 11
PREV || NEXT